Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE 250

598.00p
   
  • Change Today:
      4.00p
  • 52 Week High: 682.00
  • 52 Week Low: 232.50
  • Currency: UK Pounds
  • Shares Issued: 120.50m
  • Volume: 48,826
  • Market Cap: £720.57m
  • RiskGrade: 125

Regulatory News

Holding(s) in Company 03-Nov-2025 16:55 RNS
Total Voting Rights 03-Nov-2025 07:00 RNS
Director/PDMR Shareholding 20-Oct-2025 17:54 RNS
Director/PDMR Shareholding 20-Oct-2025 17:13 RNS
Board Change 20-Oct-2025 10:17 RNS
Director/PDMR Shareholding 16-Oct-2025 07:00 RNS
Acquisition of US viral vector facility 07-Oct-2025 07:00 RNS
Total Voting Rights 01-Oct-2025 07:00 RNS
Interim Results for 6 months ended 30 June 2025 23-Sep-2025 07:00 RNS
Total Voting Rights 01-Sep-2025 07:00 RNS
PDMR Dealings 22-Aug-2025 15:36 RNS
Holding(s) in Company 21-Aug-2025 10:24 RNS
Admission of Shares and Total Voting Rights 20-Aug-2025 07:00 RNS
PDMR Dealings 15-Aug-2025 13:45 RNS
Results of Placing 15-Aug-2025 07:05 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

OXB Market Data

Currency UK Pounds
Share Price 598.00p
Change Today 4.00p
% Change 0.67 %
52 Week High 682.00
52 Week Low 232.50
Volume 48,826
Shares Issued 120.50m
Market Cap £720.57m
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
35.16% below the market average35.16% below the market average35.16% below the market average35.16% below the market average35.16% below the market average
17.07% above the sector average17.07% above the sector average17.07% above the sector average17.07% above the sector average17.07% above the sector average
Price Trend
84.11% above the market average84.11% above the market average84.11% above the market average84.11% above the market average84.11% above the market average
86.36% above the sector average86.36% above the sector average86.36% above the sector average86.36% above the sector average86.36% above the sector average
Income Not Available
Growth
5.07% above the market average5.07% above the market average5.07% above the market average5.07% above the market average5.07% above the market average
24.14% below the sector average24.14% below the sector average24.14% below the sector average24.14% below the sector average24.14% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 4
Sell 0
Strong Sell 0
Total 10
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

OXB Dividends

No dividends found

Trades for 20-Nov-2025

Time Volume / Share Price
14:40 1 @ 598.00p
14:40 13 @ 598.00p
14:40 3 @ 598.00p
14:40 10 @ 598.00p
14:40 1 @ 601.00p

OXB Key Personnel

Chair Roch Doliveux
CEO Frank Mathias
CFO Lucinda (Lucy) Crabtree

Top of Page